
Recent developments with Marker Therapeutics Inc (MRKR) have led to the company’s beta value being reach 1.46 cents.
Marker Therapeutics Inc (NASDAQ: MRKR) on Monday, plunged -10.00% from the previous trading day, before settling in for the closing price of $1.7. Within the